| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
On CNBC's “Halftime Report Final Trades,” Stephen L. Weiss of Short Hills Capital Partners recommended buying TransDigm Group Incorporated (NYSE:TDG).
On Aug. 6, TransDigm Group reported better-than-expected third-quarter financial results and raised its FY24 guidance above estimates.
Jason Snipe of Odyssey Capital Advisors said BJ’s Wholesale Club Holdings, Inc. (NYSE:BJ) beat on the bottom line.
On Aug. 22, BJ’s Wholesale reported better-than-expected second-quarter financial results. Revenue growth of 4.9% Y/Y to $5.205 billion, beating the analyst consensus estimate of $5.145 billion. Total comparable club sales increased by 3.1%. Comparable club sales, excluding gasoline sales, increased by 2.4%.
Don't forget to check out our premarket coverage here
Anastasia Amoroso of iCapital picked VanEck Semiconductor ETF (NASDAQ:SMH), saying semiconductor space is down 17%, so it's a good place to add.
Joe Terranova of Virtus Investment Partners named AbbVie Inc. (NYSE:ABBV) as his final trade.
On Sept. 10, AbbVie’s CONSTELLA received Health Canada approval for treating childhood constipation. “Constipation is a common issue in childhood that can significantly impact a child’s quality of life and cause considerable stress for their families. These children and families will be grateful to have a new prescription treatment option that can offer symptom relief and improve the overall well-being of the child and family, making daily life more manageable,” said Dr. Melanie Schmidt, Division of Paediatric Gastroenterology and Hepatology at Children’s Hospital in London, Ontario.
Price Action:
Check This Out:
Image generated using artificial intelligence via Midjourney.
